Arysta sales down 16% on currency effects
The strengthening of the yen against other major currencies led to a 15.9% decline in Arysta LifeScience’s annual agrochemical sales in 2009 to ¥101,719 million ($1,095.5 million at the current rate). The currency impact was accentuated not only by the weakening of major currencies, such as the US dollar and the euro, but also secondary currencies of importance to Arysta, including the Brazilian real, Mexican peso, Polish zloty and South African rand, against the yen. At constant exchange rates (CER), the downturn in revenues was a more moderate 5%. Agrochemicals represented 92% of Arysta’s total sales of ¥111,761 million ($1,203.7 million), which include pharmaceuticals and veterinary products.